- Home
- BCRX vs EVT Comparison
BCRX vs EVT Comparison
Compare BCRX & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- EVT
- Stock Information
- Founded
- BCRX 1986
- EVT 2003
- Country
- BCRX United States
- EVT United States
- Employees
- BCRX N/A
- EVT N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- EVT Finance Companies
- Sector
- BCRX Health Care
- EVT Finance
- Exchange
- BCRX Nasdaq
- EVT Nasdaq
- Market Cap
- BCRX 1.9B
- EVT 1.8B
- IPO Year
- BCRX 1994
- EVT N/A
- Fundamental
- Price
- BCRX $9.21
- EVT $23.95
- Analyst Decision
- BCRX Buy
- EVT
- Analyst Count
- BCRX 6
- EVT 0
- Target Price
- BCRX $15.50
- EVT N/A
- AVG Volume (30 Days)
- BCRX 3.0M
- EVT 121.5K
- Earning Date
- BCRX 02-24-2025
- EVT 01-01-0001
- Dividend Yield
- BCRX N/A
- EVT 7.72%
- EPS Growth
- BCRX N/A
- EVT N/A
- EPS
- BCRX N/A
- EVT N/A
- Revenue
- BCRX $412,579,000.00
- EVT N/A
- Revenue This Year
- BCRX $38.44
- EVT N/A
- Revenue Next Year
- BCRX $21.23
- EVT N/A
- P/E Ratio
- BCRX N/A
- EVT N/A
- Revenue Growth
- BCRX 29.92
- EVT N/A
- 52 Week Low
- BCRX $4.03
- EVT $18.70
- 52 Week High
- BCRX $9.50
- EVT $23.82
- Technical
- Relative Strength Index (RSI)
- BCRX 65.48
- EVT 35.60
- Support Level
- BCRX $8.63
- EVT $24.12
- Resistance Level
- BCRX $9.00
- EVT $24.46
- Average True Range (ATR)
- BCRX 0.36
- EVT 0.26
- MACD
- BCRX 0.07
- EVT -0.05
- Stochastic Oscillator
- BCRX 85.20
- EVT 2.83
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.